Inhaled antimicrobial chemotherapy for respiratory tract infections: successes,challenges and the road ahead |
| |
| Affiliation: | 1. Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney 2006, New South Wales, Australia;2. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, 381 Royal Parade, Parkville, Victoria 3052, Australia;1. Dept of Biomedical Engineering, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;2. Advanced Platform Technology Center of Excellence, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA;3. Dept of Urology, UKT, University of Tübingen, Tübingen, Germany;4. Dept of Urology, UKSH, Campus Lübeck, University of Lübeck, Lübeck, Germany;5. Dept of Urology and Andrology, Uro-Oncology, Neurourology, Incontinence and Reconstructive Urology, Paracelsus Medical University, Salzburg, Austria;1. Membrane Dynamics, Department of Biology, Technische Universität Darmstadt, Schnittspahnstrasse 3-5, 64287 Darmstadt, Germany;2. Institute of Health and Biomedical Innovation, Science and Engineering Faculty, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, 4059 QLD, Brisbane, Australia;1. Department of Pharmaceutical Biosciences, Translational PKPD Research Group, Uppsala University, Associate member of SciLife Lab, Box 591, Uppsala SE-75124, Sweden;2. Respiratory, Inflammation and Autoimmunity innovative Medicines, AstraZeneca R&D, Mölndal, Sweden |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
